• National University of Singapore Featured PhD Programmes
  • University of Leeds Featured PhD Programmes
  • Cardiff University Featured PhD Programmes
  • University of Leeds Featured PhD Programmes
  • University of Glasgow Featured PhD Programmes
  • London School of Economics and Political Science Featured PhD Programmes
  • University of East Anglia Featured PhD Programmes
  • University of Oxford Featured PhD Programmes
Norwich Research Park Featured PhD Programmes
King’s College London Featured PhD Programmes
University of Oxford Featured PhD Programmes
John Innes Centre Featured PhD Programmes
Peter MacCallum Cancer Centre Featured PhD Programmes

Therapeutic models for Spinal muscular atrophy

  • Full or part time
  • Application Deadline
    Applications accepted all year round
  • Self-Funded PhD Students Only
    Self-Funded PhD Students Only

Project Description

Our laboratory works on Gene Therapy in the Central Nervous System and Gene Repair, using novel viral vectors, gene targeting and induced pluripotent stem cells (iPSCs) as core technologies. Standard lentivectors are very efficient tools for gene therapy and gene transfer, but their integration in the host cell genome can lead to insertional mutagenesis and position effect variegation (Gabriel et al., 2009). We have recently developed integration-deficient lentiviral vectors (IDLVs) through the use of mutations in the viral integrase. Failing to integrate in the host cell genome, these vectors are instead converted into episomal circles, which lack replication signals and are diluted out through cell division (Wanisch and Yáñez-Muñoz, 2009). Gene expression from the viral episomes is transient in dividing cells but long-lived in quiescent tissues, including eye, brain, spinal cord and muscle (Yáñez-Muñoz et al., 2006; Peluffo et al., submitted).

We are particularly interested in applying these vectors to relevant models of Spinal muscular atrophy (SMA), a neuromuscular disorder affecting motor neurons. To study molecular mechanisms of disease and assess novel therapies we have produced iPSCs from several members of an SMA family whose symptoms are of varying severity. We are now seeking applicants to develop the iPSC-based models and test the efficacy of novel IDLVs for therapy of SMA. Project available immediately but only suitable to self-funded students or those in receipt of a personal fellowship; in addition, payment of bench fees will be required. For additional information please visit: http://pure.rhul.ac.uk/portal/en/persons/rafael-yanez_7a966e44-a812-4293-99a8-1016a6fe919a.html

References

Gabriel, R., Eckenberg, R., Paruzynski, A., Bartholomae, C.C., Nowrouzi, A., Arens, A., Howe, S.J., Recchia, A., Cattoglio, C., Wang, W., Faber, K., Schwarzwaelder, K., Kirsten, R., Deichmann, A., Ball, C.R., Balaggan, K.S., Yáñez-Muñoz, R.J., Ali, R.R., Gaspar, H.B., Biasco, L., Aiuti, A., Cesana, D., Montini, E., Naldini, L., Cohen-Haguenauer, O., Mavilio, F., Thrasher, A.J., Glimm, H., von Kalle, C., Saurin, W. and Schmidt, M. (2009) Comprehensive genomic access to vector integration in clinical gene therapy. Nat Med 15, 1431-1436. doi:10.1038/nm.2057.

Peluffo, H., Foster, E., Ahmed, S.G., Lago, N., Hutson, T., Moon, L., Yip, P., Wanisch, K., Caraballo-Miralles, V., Lladó, J., McMahon, S.B. and Yáñez-Muñoz, R.J. (2011) Efficient gene expression from non-integrating lentiviral vectors in the spinal cord. Submitted.

Wanisch, K. and Yáñez-Muñoz, R.J. (2009) Integration-deficient lentiviral vectors: a slow coming of age. Mol Ther 17, 1316-1332. doi:10.1038/mt.2009.122.

Yáñez-Muñoz, R.J., Balaggan, K.S., MacNeil, A., Howe, S., Schmidt, M., Smith, A.J., Buch, P., MacLaren, R.E., Anderson, P.N., Barker, S., Duran, Y., Bartholomae, C., von Kalle, C., Heckenlively, J.R., Kinnon, C., Ali, R.R. and Thrasher, A.J. (2006) Effective gene therapy with nonintegrating lentiviral vectors. Nat Med 12, 348-353. doi:10.1038/nm1365



How good is research at Royal Holloway, University of London in Biological Sciences?

FTE Category A staff submitted: 24.00

Research output data provided by the Research Excellence Framework (REF)

Click here to see the results for all UK universities

Email Now

Insert previous message below for editing? 
You haven’t included a message. Providing a specific message means universities will take your enquiry more seriously and helps them provide the information you need.
Why not add a message here
* required field
Send a copy to me for my own records.

Your enquiry has been emailed successfully




Cookie Policy    X